Development of a Cuproptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Colorectal Cancer

Figure S1 The expression of CRGs in CRC and its relationship with lncRNA. (A) CRG expression in TCGA-cohort and non-paired normal tissues. (B) CRG expression in TCGA-cohort and paired normal tissues. (C) The Sankey diagram shows the detailed correlation between CRLs and CRGs.

Figure S2 Correlation between the eight CRL and clinical features. (A) Cuproptosis-related lncRNAs expression in TCGA-cohort and non-paired normal tissues. (B) Cuproptosis-related genes lncRNAs expression in TCGA-cohort in CRC and paired normal tissues. (C) The correlation between the expression of eight CRL and clinicopathological stage *: P < 0.05.

Figure S3 Correlation between the eight CRL and clinical features. The relationship between the expression of the eight CRL and clinicopathological stage (A)N and (B)M. NS: Not Significant, *: P < 0.05. Note: N: Node, classified into N1, N2, and N3; M: metastasis, classified into M0 and M1 (C-F) KM curves shows the OS of patients based on the expression of SEPTIN7-DT, ZEB1-AS1, TNFRSF10A-AS1, and ALMS1-1T1. (G) The ROC for eight OS-related CRLs for CRC cohorts (H) Calibration curve analysis.